Science Explorer Interactive view Map
Company · Wuhan · China

Wuhan YZY Biopharma (China)

Research works
67
▲ 220% vs 2013–17
Citations
930
13.9 per fractional work
Top-10% rate
27.3%
record average 16.5%
Open access
62%
world 28%

Not ranked overall: Wuhan YZY Biopharma (China) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.55× its world share, 3 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.90× its world share, 9 worksBiochemistry, Geneti…Immunology and Microbiology: 6.36× its world share, 2 worksImmunology and Micro…Neuroscience: 1.36× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.75× its world share, 0 worksPharmacology, Toxico…Chemical Engineering: 0.27× its world share, 0 worksChemical EngineeringChemistry: 1.34× its world share, 1 worksChemistryComputer Science: 0.47× its world share, 1 worksComputer ScienceEngineering: 0.51× its world share, 3 worksEngineeringEnvironmental Science: 0.10× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.73× its world share, 1 worksMaterials SciencePhysics and Astronomy: 0.21× its world share, 0 worksPhysics and AstronomyDentistry: 1.31× its world share, 0 worksDentistryHealth Professions: 0.06× its world share, 0 worksHealth ProfessionsMedicine: 2.03× its world share, 14 worksMedicineNursing: 0.49× its world share, 0 worksNursingPsychology: 0.08× its world share, 0 worksPsychologySocial Sciences: 0.01× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.4×. Every wedge is a field page.

Which keywords describe research at Wuhan YZY Biopharma (China)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Tumor Regression, Cancer Immunotherapy, Gene Therapy, Lymphoma, CAR T Cells, Chimeric Antigen Receptor and AAV.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 29 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 29 words, with their numbers
  1. Immunotherapy4▲ 17×10 topics
  2. Tumor Regression3▲ 88×2 topics
  3. Cancer Immunotherapy3▲ 60×3 topics
  4. Gene Therapy3▲ 42×3 topics
  5. Lymphoma2▲ 42×2 topics
  6. CAR T Cells2▲ 91×1 topic
  7. Chimeric Antigen Receptor2▲ 91×1 topic
  8. Epidemiology2▲ 1.32×13 topics
  9. Oxidative Stress2▲ 2.6×14 topics
  10. Cancer1▲ 3.0×16 topics
  11. AAV1▲ 96×1 topic
  12. Immunity1▲ 9.0×5 topics
  13. Inflammation1▲ 1.77×11 topics
  14. Tumor Microenvironment1▲ 8.1×6 topics
  15. Viral Vectors1▲ 96×1 topic
  16. Biosensors1▲ 6.7×6 topics
  17. Glycosylation1▲ 31×3 topics
  18. Prenatal Diagnosis1▲ 23×3 topics
  19. Tumor Targeting1▲ 19×3 topics
  20. Immune Response1▲ 5.7×9 topics
  21. Innate Immunity1▲ 10.0×5 topics
  22. Sustainability1▲ 1.30×2 topics
  23. Vaccine1▲ 7.8×6 topics
  24. Aquaponics1▲ 209×1 topic
  25. Arginine Deprivation1▲ 82×1 topic
  26. Bacterial Therapy1▲ 82×1 topic
  27. Hydroponics1▲ 42×1 topic
  28. Machine Learning1◆ 0.87×4 topics
  29. Microbial Communities1▲ 7.0×2 topics

Which research topics does Wuhan YZY Biopharma (China) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Virus-based gene therapy research, Cancer Research and Treatments and Innovations in Aquaponics and Hydroponics Systems.

  1. 1 CAR-T cell therapy research Oncology 2 works
  2. 2 Virus-based gene therapy research Genetics 1 works
  3. 3 Cancer Research and Treatments Biotechnology 1 works
  4. 4 Innovations in Aquaponics and Hydroponics Systems Aquatic Science 1 works
  5. 5 Cancer Immunotherapy and Biomarkers Oncology 1 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  7. 7 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 1 works
  8. 8 Immunotherapy and Immune Responses Immunology 1 works
  9. 9 Prenatal Screening and Diagnostics Pediatrics, Perinatology and Child Health 0 works
  10. 10 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available62.4%not open37.6%

World: 28% of research is openly available.

with international co-authors11.5%domestic only88.5%

World: 19% is written across borders.

How has Wuhan YZY Biopharma (China)'s research output changed?

Output in 2018–2022 was 220% higher than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Wuhan

All research institutions in Wuhan

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.